171 related articles for article (PubMed ID: 33393209)
1. In vitro hepatic steatosis model based on gut-liver-on-a-chip.
Jeon JW; Lee SH; Kim D; Sung JH
Biotechnol Prog; 2021 May; 37(3):e3121. PubMed ID: 33393209
[TBL] [Abstract][Full Text] [Related]
2. Gut-liver on a chip toward an in vitro model of hepatic steatosis.
Lee SY; Sung JH
Biotechnol Bioeng; 2018 Nov; 115(11):2817-2827. PubMed ID: 29981260
[TBL] [Abstract][Full Text] [Related]
3. Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device.
Gori M; Simonelli MC; Giannitelli SM; Businaro L; Trombetta M; Rainer A
PLoS One; 2016; 11(7):e0159729. PubMed ID: 27438262
[TBL] [Abstract][Full Text] [Related]
4. Endogenous formation of Nε-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis.
Gaens KH; Niessen PM; Rensen SS; Buurman WA; Greve JW; Driessen A; Wolfs MG; Hofker MH; Bloemen JG; Dejong CH; Stehouwer CD; Schalkwijk CG
J Hepatol; 2012 Mar; 56(3):647-55. PubMed ID: 21907687
[TBL] [Abstract][Full Text] [Related]
5. Microfluidic Gut-liver chip for reproducing the first pass metabolism.
Choe A; Ha SK; Choi I; Choi N; Sung JH
Biomed Microdevices; 2017 Mar; 19(1):4. PubMed ID: 28074384
[TBL] [Abstract][Full Text] [Related]
6. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
7. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
8. A body-on-a-chip (BOC) system for studying gut-liver interaction.
Sung JH
Methods Cell Biol; 2020; 158():1-10. PubMed ID: 32423644
[TBL] [Abstract][Full Text] [Related]
9. A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease.
Schleicher J; Guthke R; Dahmen U; Dirsch O; Holzhuetter HG; Schuster S
Biochim Biophys Acta; 2014 Jan; 1841(1):62-9. PubMed ID: 23999488
[TBL] [Abstract][Full Text] [Related]
10. Investigation of steatosis profiles induced by pesticides using liver organ-on-chip model and omics analysis.
Jellali R; Jacques S; Essaouiba A; Gilard F; Letourneur F; Gakière B; Legallais C; Leclerc E
Food Chem Toxicol; 2021 Jun; 152():112155. PubMed ID: 33775782
[TBL] [Abstract][Full Text] [Related]
11. Liver-specific Repin1 deficiency impairs transient hepatic steatosis in liver regeneration.
Abshagen K; Degenhardt B; Liebig M; Wendt A; Genz B; Schaeper U; Stumvoll M; Hofmann U; Frank M; Vollmar B; Klöting N
Sci Rep; 2018 Nov; 8(1):16858. PubMed ID: 30442920
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis.
Liu J; Jin X; Yu CH; Chen SH; Li WP; Li YM
J Gastroenterol Hepatol; 2010 Mar; 25(3):613-8. PubMed ID: 19929925
[TBL] [Abstract][Full Text] [Related]
13. Quercetin and hydroxytyrosol as modulators of hepatic steatosis: A NAFLD-on-a-chip study.
Gori M; Giannitelli SM; Zancla A; Mozetic P; Trombetta M; Merendino N; Rainer A
Biotechnol Bioeng; 2021 Jan; 118(1):142-152. PubMed ID: 32889748
[TBL] [Abstract][Full Text] [Related]
14.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
15. Hepatitis B Virus X Protein Induces Hepatic Steatosis by Enhancing the Expression of Liver Fatty Acid Binding Protein.
Wu YL; Peng XE; Zhu YB; Yan XL; Chen WN; Lin X
J Virol; 2016 Feb; 90(4):1729-40. PubMed ID: 26637457
[TBL] [Abstract][Full Text] [Related]
16. Human hepatic 3D spheroids as a model for steatosis and insulin resistance.
Kozyra M; Johansson I; Nordling Å; Ullah S; Lauschke VM; Ingelman-Sundberg M
Sci Rep; 2018 Sep; 8(1):14297. PubMed ID: 30250238
[TBL] [Abstract][Full Text] [Related]
17. 3D gut-liver chip with a PK model for prediction of first-pass metabolism.
Lee DW; Ha SK; Choi I; Sung JH
Biomed Microdevices; 2017 Nov; 19(4):100. PubMed ID: 29116458
[TBL] [Abstract][Full Text] [Related]
18. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
19. Induction of Liver Steatosis in BAP31-Deficient Mice Burdened with Tunicamycin-Induced Endoplasmic Reticulum Stress.
Wu Z; Yang F; Jiang S; Sun X; Xu J
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30081561
[TBL] [Abstract][Full Text] [Related]
20. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
